BTMD
bioteDNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
The constructive read is that management maintained full-year revenue and adjusted EBITDA targets despite a recall-related Q1 disruption, while reiterating expected second-half procedure growth and continued sales-force build-out. That supports a recovery setup if supply continuity improves quickly.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Biote disclosed that Asteria Health and related outsourcing facilities have received FDA warning-letter or Form 483 scrutiny, and the January 2026 voluntary recall followed FDA engagement, leaving regulatory and supplier risk elevated. [#10-K-2026-03-13]
Momentum
31
Value
72
Sentiment
40
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.90 · Bull $3.00 · Bear $1.20
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $4.21
Why
Momentum31 · Δ7d -
Value72 · Δ7d +0.0
Sentiment40 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
31
34% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
72
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.4
Sentiment
40
33% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade D. Momentum 31.4 / Value 71.8 / Sentiment 40.0
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$80.8M
Beta
1.16
Shares Out
45.66M
P/E (TTM)
2.9
P/S (TTM)
0.58
P/FCF (TTM)
3.28
Rev YoY
-6.7%
EPS YoY
-32.8%
Gross Margin
+72.2%
Op Margin
+16.1%
Net Debt
$136.98M
Current Ratio
1.01
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology